Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer
Bendell, J., Ciardiello, F., Tabernero, J., Tebbutt, N., Eng, C., Di Bartolomeo, M., Falcone, A., Fakih, M., Kozloff, M., Segal, N., Sobrero, A., Shi, Y., Roberts, L., Yan, Y., Chang, I., Uyei, A., Kim, T.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center
Ready, K., Arun, B. K., Schmeler, K. M., Uyei, A., Litton, J. K., Lu, K. H., Sun, C. C., Peterson, S. K.
Published in Familial cancer (01.12.2011)
Published in Familial cancer (01.12.2011)
Get full text
Journal Article
SO-32 Biomarker analysis of the phase III IMblaze370 trial of atezolizumab plus cobimetinib or atezolizumab monotherapy vs regorafenib in third-line CRC
Argiles, G., Bendell, J., Kim, T., Wongchenko, M., DuPree, K., Mahrus, S., Qu, X., Shi, Y., Uyei, A., Roberts, L., Yan, Y., Ciardiello, F.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
LBA-004Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer
Bendell, J, Ciardiello, F, Tabernero, J, Tebbutt, N, Eng, C, Di Bartolomeo, M, Falcone, A, Fakih, M, Kozloff, M, Segal, N, Sobrero, A, Shi, Y, Roberts, L, Yan, Y, Chang, I, Uyei, A, Kim, T
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box/Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation
Qiu, Daoming, Zhao, Guohua, Aoki, Yosuke, Shi, Lingfang, Uyei, Anne, Nazarian, Saman, Ng, James C.-H., Kao, Peter N.
Published in The Journal of biological chemistry (07.05.1999)
Published in The Journal of biological chemistry (07.05.1999)
Get full text
Journal Article
Clinical factors that affect breast cancer risk reduction decisions in high risk women tested for the BRCA1/2 genetic mutation
Uyei, A. R., Broglio, K. R., Solomon, T. L., Vogel, K. J., Amos, C. I., Lu, K., Meric-Bernstam, F., Strong, L., Arun, B.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Immunosuppressant PG490 (Triptolide) inhibits t-cell interleukin-2 expression at the level of purine box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation
Qui, D, Zhao, G, Aoki, Y, Shi, L, Uyei, A, Nazarian, S, Ng, J.C.H, Kao, P.N
Published in The Journal of biological chemistry (07.05.1999)
Get full text
Published in The Journal of biological chemistry (07.05.1999)
Journal Article